{
  "id": "5e763645c6a8763d2300000d",
  "type": "yesno",
  "question": "Has ORMD-0801 been tested in patients?",
  "ideal_answer": "Yes, ORMD-0801 has been tested in patients.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23593142"
  ],
  "snippets": [
    {
      "text": "Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23593142",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In efforts to provide patients with a more compliable treatment method, Oramed Pharmaceuticals tested the capacity of its oral insulin capsule (ORMD-0801, 8 mg insulin) in addressing this resistant clinical state.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23593142",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}